← Insider buys
MRNS

Marinus Pharmaceuticals, Inc.

Bain Capital Life Sciences Investors, LLC sold $10.0M of Marinus Pharmaceuticals, Inc.

10% owner

Sold$10,024,801
$7.88Price
1,272,547Shares
−24%Stake

What MRNS did after the filing

Prices for MRNS after this filing aren't in yet.

Traded Fri, Dec 15. Filed Tue, Dec 19. Not investment advice.